EAACI Congress 2025

Back

13 - 16 June 2025 Glasgow, United Kingdom

FT22 - Chronic rhinosinusitis: from bedside to bench

Monday 16 Jun, 10:45 AM - 12:15 PM Glasgow, United Kingdom

Dochart 1 Flash Talks

10:45 001368

The Clinical Characteristics and Inflammatory Endotypes of Chronic Rhinosinusitis with Nasal Polyps in Southern China: A Multi-Center, Cross Section study

Zhaofeng Xu (China)

10:52 000929

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Martin Wagenmann (Germany)

10:59 001682

Effectiveness of Dupilumab in Severe CRSwNP: A Brazilian Study

Maria Eduarda Trocoli Zanetti (Brazil)

11:06 001018

Endotype in nasal inflammatory diseases using minimally invasive sampling techniques

Pauline Janssen (Belgium)

11:13 001309

A comparative analysis of pediatric and adult endotypes of chronic rhinosinusitis

Gwanghui Ryu (Korea, Republic of)

11:20 000277

Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps

Xin Feng (China)

11:27 001230

Hippo-YAP inhibits the autophagic degradation of Cyclin D1 in chronic rhinosinusitis with nasal polyps

Mingrui Pan (China)

11:34 000728

Site-specific proteomics reveals key molecular features underlying the transition to nasal polyps

Yi-Sook Kim (Korea, Republic of)

11:41 000769

A Regulatory Risk haplotype in HLA-DQ region regulates antigen presentation of monocyte in Type 2 inflammation in chronic rhinosinusitis with nasal polyps

Jingyun Li (China)